- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Lexeo Therapeutics Inc.
Headquarters: New York , NY, United States of America
Website: https://www.lexeotx.com/
Year Founded: 2017
Status: Public
Industry Sector: HealthTechnology
CEO: R. Nolan Townsend, MBA
Number Of Employees: 58
Enterprise Value: $247,766,393
PE Ratio: -1.04
Exchange/Ticker 1: NASDAQ:LXEO
Exchange/Ticker 2: N/A
Latest Market Cap: $98,205,704
BioCentury | Nov 6, 2024
Product Development
Alzheimer’s roundup: Clinical progress and setbacks at CTAD
Readouts showcase promise of Roche’s brainshuttle; plus mixed results from Lilly, Lexeo and Anavex
BioCentury | Mar 15, 2024
Finance
Public equity report: PIPEs for Lexicon, Cybin, Regulus, Lexeo
Companies raise cash as they eye paths forward in diabetes, depression, kidney disease and Friedreich ataxia
BioCentury | Feb 7, 2024
Management Tracks
Verily names Myoung Cha as chief product officer
Plus: New CFO for Innovent and updates from Takeda, Shionogi, Lexeo, Stuart, Arcellx and more
BioCentury | Jan 12, 2024
Finance
The year of biotech’s recovery
Public Markets Preview: Investors say biotech outperformance in 2024 will hinge on the interest rate environment
BioCentury | Nov 10, 2023
Product Development
Nov. 10 Quick Takes: Cargo biggest biotech IPO to dip on first day
Plus: Madrigal identifies non-invasive efficacy assessment for NASH and updates from Novo and Valneva
BioCentury | Nov 7, 2023
Regulation
A DMD decision & endpoint innovation: a BioCentury podcast
Plus: FDA’s single trial guidance, the Promising Pathway Act and Lexeo’s NASDAQ debut
BioCentury | Nov 3, 2023
Finance
Lexeo cuts IPO price, becomes latest to lose value in first session
With gene therapy company’s dip Friday, seven of 10 major 2023 NASDAQ biotech listings have now traded down in the aftermarket since pricing
BioCentury | Oct 2, 2023
Regulation
Oct. 2 Quick Takes: Takeda withdrawing Exkivity after confirmatory miss
Plus: Novartis’ iptacopan shows benefit in IgA nephropathy and updates from Mirum, Lexeo, Rocket, Lilly, Syndax, SAB, Amicus and Pneumagen
Items per page:
1 - 8 of 8